X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs IPCA LABS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER IPCA LABS PFIZER/
IPCA LABS
 
P/E (TTM) x 28.7 39.0 73.5% View Chart
P/BV x 4.6 3.0 152.3% View Chart
Dividend Yield % 0.7 0.2 413.9%  

Financials

 PFIZER   IPCA LABS
EQUITY SHARE DATA
    PFIZER
Mar-16
IPCA LABS
Mar-17
PFIZER/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs2,724643 423.6%   
Low Rs1,611503 320.4%   
Sales per share (Unadj.) Rs440.9254.4 173.3%  
Earnings per share (Unadj.) Rs48.716.1 303.0%  
Cash flow per share (Unadj.) Rs75.829.8 254.5%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %0.70.2 396.5%  
Book value per share (Unadj.) Rs462.9194.6 238.0%  
Shares outstanding (eoy) m45.75126.20 36.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.3 218.3%   
Avg P/E ratio x44.535.7 124.9%  
P/CF ratio (eoy) x28.619.2 148.7%  
Price / Book Value ratio x4.72.9 159.0%  
Dividend payout %30.86.2 495.0%   
Avg Mkt Cap Rs m99,16372,300 137.2%   
No. of employees `0002.913.3 21.7%   
Total wages/salary Rs m2,7586,960 39.6%   
Avg. sales/employee Rs Th6,981.72,413.5 289.3%   
Avg. wages/employee Rs Th954.5523.2 182.4%   
Avg. net profit/employee Rs Th771.1152.4 505.8%   
INCOME DATA
Net Sales Rs m20,17032,106 62.8%  
Other income Rs m857226 379.9%   
Total revenues Rs m21,02832,332 65.0%   
Gross profit Rs m4,3104,448 96.9%  
Depreciation Rs m1,2391,730 71.6%   
Interest Rs m5241 2.2%   
Profit before tax Rs m3,9232,703 145.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794675 265.8%   
Profit after tax Rs m2,2282,028 109.9%  
Gross profit margin %21.413.9 154.2%  
Effective tax rate %45.725.0 183.1%   
Net profit margin %11.06.3 174.9%  
BALANCE SHEET DATA
Current assets Rs m16,29917,340 94.0%   
Current liabilities Rs m7,5949,559 79.4%   
Net working cap to sales %43.224.2 178.1%  
Current ratio x2.11.8 118.3%  
Inventory Days Days65100 65.1%  
Debtors Days Days2657 45.3%  
Net fixed assets Rs m8,62220,779 41.5%   
Share capital Rs m458252 181.3%   
"Free" reserves Rs m20,72224,499 84.6%   
Net worth Rs m21,18024,553 86.3%   
Long term debt Rs m253,517 0.7%   
Total assets Rs m29,13739,595 73.6%  
Interest coverage x755.512.2 6,179.3%   
Debt to equity ratio x00.1 0.8%  
Sales to assets ratio x0.70.8 85.4%   
Return on assets %7.75.7 133.7%  
Return on equity %10.58.3 127.3%  
Return on capital %19.010.5 181.1%  
Exports to sales %0.148.6 0.1%   
Imports to sales %17.514.2 122.8%   
Exports (fob) Rs m1215,617 0.1%   
Imports (cif) Rs m3,5264,571 77.1%   
Fx inflow Rs m5215,617 0.3%   
Fx outflow Rs m1405,828 2.4%   
Net fx Rs m-889,790 -0.9%   
CASH FLOW
From Operations Rs m3,4362,764 124.3%  
From Investments Rs m-6,991-1,432 488.3%  
From Financial Activity Rs m-619-1,591 38.9%  
Net Cashflow Rs m-4,174-259 1,612.6%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.4 65.8%  
FIIs % 4.9 25.3 19.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.4 136.2%  
Shareholders   85,207 36,892 231.0%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Rally, IMF's GDP Prediction, and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in green and ended on a positive note. The BSE Sensex closed higher by 342 points to close above 36,000 levels for the first time ever.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 23, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS